Table. 2.

Table. 2.

5-year relative survival of AYA and children with cancer common to both groups. Europe data from 27 European countries participating in EUROCARE-5 for AYA and children with cancer diagnosed in 2000-2007. US Data from NCI SEER database in the period from 2002-2006

ALL AML RMS Ewing’s sarcoma Hodgkin lymphoma NHL Astrocytoma Osteosarcoma
The US [47]
AYA 52% 50% 43% 54%
Children 90% 66% 69% 77%
Europe [46]
AYA 55.6% 49.8% 37.8% 49.3% 92.9% 77.4% 46.4% 61.5%
Children 85.8% 60.5% 66.6% 66.6% 95.1% 83.0% 61.9% 66.8%

ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; RMS, rhabdomyosarcoma; NHL, Non-Hodgkin lymphoma.

Clin Pediatr Hematol Oncol 2021;28:1-13
© 2021 Clin Pediatr Hematol Oncol